Embecta Corp (EMBC) Stock Price, Quote & News

Company Profile

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headqu...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 862 401 0000

Website: www.embecta.com

Address:

300 Kimball Drive, Suite 300, Parsippany, United States

SuperGreenToday Dec. 5 at 10:25 AM

$EMBC Share Price: $11.67 Contract Selected: May 15, 2026 $10 Calls Buy Zone: $2.23 – $2.76 Target Zone: $3.79 – $4.64 Potential Upside: 60% ROI Time to Expiration: 160 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Arcides Nov. 26 at 6:44 PM

$EMBC wrecked...

0 · Reply

yosiyosi Nov. 25 at 12:45 PM

$EMBC buy more

0 · Reply

BEATOFtheMARKET Nov. 17 at 12:13 AM

$EGY $ELA $ELP $EMBC $ENLT

0 · Reply

NJgolfer Nov. 13 at 3:13 AM

$EMBC hardly followed stock shows a buy signal today.

0 · Reply

ChaseDeluca Oct. 15 at 1:53 AM

GIPR is one of those rare tickers with built-in value and upside surprise potential. Real property assets, low risk, and whispers of crypto treasury ambitions. If they deliver on that pivot, GIPR could be redefining how real estate + digital assets converge... $FAD $EMBC $ILAG $ARVL $VXRT

0 · Reply

Fugazi_ Sep. 22 at 2:17 PM

$EMBC Someone is still holding 40k usd worth of call options at 17.5 for next month. I want to see why

0 · Reply

BillStoneberg455 Sep. 21 at 10:54 AM

$EMBC Healthcare technology niche. Thin volume trading. No clear pattern emerging. Avoid.

0 · Reply

FinJay Sep. 15 at 3:34 AM

$EMBC https://youtu.be/gcJPjjJi914

0 · Reply

G101SPM Sep. 9 at 3:09 PM

G101SPM 8/19/2025, 10:03:19 AM $EMBC 2023 closeout at a loss as random algorithm data. Misplaced data / registered as computer hallucination to a 12.31.23 closeout at a loss.

1 · Reply

Embecta Growth Stalls Despite Strong Fiscal 2025 Results (Rating Downgrade)

Nov 26, 2025, 10:37 AM EST - 10 days ago

Meet 33 Ideal "Safer" November Small/MidCap Value DiviBuys Of The S&P600

AAT AUB BBT CPF CRGY CVBF DCOM

Nov 25, 2025, 11:23 AM EST - 11 days ago

Embecta Corp. (EMBC) Q4 2025 Earnings Call Transcript

Nov 25, 2025, 6:30 AM EST - 11 days ago

Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance

Nov 25, 2025, 6:00 AM EST - 11 days ago

embecta Announces Quarterly Cash Dividend

Nov 17, 2025, 5:00 PM EST - 19 days ago

embecta announces changes to Board of Directors

Nov 14, 2025, 6:30 AM EST - 22 days ago

embecta Announces Major New Commitment to Direct Relief on World Diabetes Day

Nov 11, 2025, 5:00 PM EST - 25 days ago

embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results

Oct 22, 2025, 6:08 PM EDT - 6 weeks ago

Meet 22 Ideal "Safer" October Small Cap DiviDogs Of The S&P600

AAT AESI CCOI CSR CVBF DEI DLX

Aug 31, 2025, 6:54 AM EDT - 3 months ago

Upgrading Embecta Due To Reorganization And Growth Initiatives

Aug 28, 2025, 8:22 AM EDT - 3 months ago

Embecta: Strategic Reprioritization Holds Promise And Valuations Are Favorable

Aug 26, 2025, 5:00 PM EDT - 3 months ago

embecta to Participate in Investor Events

Aug 8, 2025, 12:08 PM EDT - 4 months ago

Embecta Corp. (EMBC) Q3 2025 Earnings Call Transcript

Aug 8, 2025, 6:30 AM EDT - 4 months ago

Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results

Jul 24, 2025, 5:00 PM EDT - 4 months ago

embecta to Report Fiscal Third Quarter 2025 Financial Results

May 22, 2025, 6:30 AM EDT - 7 months ago

embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day

May 15, 2025, 4:45 PM EDT - 7 months ago

Embecta: Not Nearly As Cheap As The 4x Forward P/E Ratio Would Imply

May 9, 2025, 1:39 PM EDT - 7 months ago

Embecta Corp. (EMBC) Q2 2025 Earnings Call Transcript

May 9, 2025, 6:30 AM EDT - 7 months ago

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results

Apr 28, 2025, 7:30 AM EDT - 7 months ago

Embecta to host Analyst and Investor Day on May 22, 2025

Apr 21, 2025, 5:00 PM EDT - 8 months ago

embecta to Report Fiscal Second Quarter 2025 Financial Results

Apr 1, 2025, 8:05 AM EDT - 8 months ago

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

Feb 28, 2025, 2:17 AM EST - 10 months ago

Embecta: Weak Outlook But Mouth-Watering Valuation Skew Risk-Reward In Favour

Feb 18, 2025, 5:00 PM EST - 10 months ago

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

Feb 6, 2025, 1:55 PM EST - 10 months ago

Embecta Corp. (EMBC) Q1 2025 Earnings Call Transcript

Feb 6, 2025, 6:30 AM EST - 10 months ago

Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results

Jan 23, 2025, 5:00 PM EST - 11 months ago

embecta to Report Fiscal First Quarter 2025 Financial Results

Jan 14, 2025, 8:01 AM EST - 11 months ago

Aehr Test Systems Posts Weak Results, Joins Trump Media & Technology Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

AEHR DJT ARDT BLCO FIP IPI

Dec 19, 2024, 5:00 PM EST - 1 year ago

embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 4, 2024, 8:30 AM EST - 1 year ago

New Initiatives Expected To Make Embecta More Profitable

Nov 27, 2024, 4:38 PM EST - 1 year ago

Overlooked Stock: EMBC

Nov 26, 2024, 2:04 PM EST - 1 year ago

Embecta Corp. (EMBC) Q4 2024 Earnings Call Transcript

Nov 26, 2024, 1:15 PM EST - 1 year ago

Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps

Nov 26, 2024, 6:30 AM EST - 1 year ago

Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs

Nov 12, 2024, 5:31 PM EST - 1 year ago

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

Nov 12, 2024, 5:00 PM EST - 1 year ago

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

Nov 7, 2024, 6:30 AM EST - 1 year ago

embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell

Sep 3, 2024, 6:30 AM EDT - 1 year ago

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

Aug 9, 2024, 10:39 AM EDT - 1 year ago

Embecta Corp. (EMBC) Q3 2024 Earnings Call Transcript

Aug 9, 2024, 6:30 AM EDT - 1 year ago

Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results

Jul 29, 2024, 8:05 AM EDT - 1 year ago

Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company

Jul 18, 2024, 5:00 PM EDT - 1 year ago

embecta to Report Fiscal Third Quarter 2024 Financial Results

Jun 24, 2024, 6:30 AM EDT - 1 year ago

embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir

Jun 20, 2024, 7:30 AM EDT - 1 year ago

Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors

May 17, 2024, 4:30 PM EDT - 1 year ago

Embecta (EMBC) CEO on Diabetes Treatment Market

May 11, 2024, 6:48 PM EDT - 1 year ago

Embecta Corp. (EMBC) Q2 2024 Earnings Call Transcript

May 9, 2024, 6:30 AM EDT - 1 year ago

Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results

Apr 23, 2024, 5:00 PM EDT - 1 year ago

embecta to Report Fiscal Second Quarter 2024 Financial Results

Mar 6, 2024, 6:00 AM EST - 1 year ago

embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes

Feb 9, 2024, 11:43 AM EST - 1 year ago

Why Embecta Stock Is Tanking Today

SuperGreenToday Dec. 5 at 10:25 AM

0 · Reply

Arcides Nov. 26 at 6:44 PM

$EMBC wrecked...

0 · Reply

yosiyosi Nov. 25 at 12:45 PM

$EMBC buy more

0 · Reply

BEATOFtheMARKET Nov. 17 at 12:13 AM

$EGY $ELA $ELP $EMBC $ENLT

0 · Reply

NJgolfer Nov. 13 at 3:13 AM

$EMBC hardly followed stock shows a buy signal today.

0 · Reply

ChaseDeluca Oct. 15 at 1:53 AM

0 · Reply

Fugazi_ Sep. 22 at 2:17 PM

$EMBC Someone is still holding 40k usd worth of call options at 17.5 for next month. I want to see why

0 · Reply

BillStoneberg455 Sep. 21 at 10:54 AM

$EMBC Healthcare technology niche. Thin volume trading. No clear pattern emerging. Avoid.

0 · Reply

FinJay Sep. 15 at 3:34 AM

$EMBC https://youtu.be/gcJPjjJi914

0 · Reply

G101SPM Sep. 9 at 3:09 PM

G101SPM 8/19/2025, 10:03:19 AM $EMBC 2023 closeout at a loss as random algorithm data. Misplaced data / registered as computer hallucination to a 12.31.23 closeout at a loss.

1 · Reply

JarvisFlow Sep. 8 at 10:00 AM

BTIG updates rating for Embecta ( $EMBC ) to Buy, target set at 25.

0 · Reply

NVDAMillionaire Sep. 4 at 6:27 PM

$EMBC Great piece that accurately captures EMBC's current position. So if you want to refresh your understanding of EMBC or learn about EMBC for the first time, this is essential reading. https://beyondspx.com/quote/EMBC/embecta-deleveraging-and-strategic-pivot-in-a-competitive-diabetes-market-embc#analysis

0 · Reply

VolumeSpreadAnalysis Aug. 23 at 1:23 PM

$EMBC Embecta Corp is facing diabetes device competition and innovation challenges

0 · Reply

IN0V8 Aug. 11 at 2:24 PM

$EMBC Mizuho raises target price to $14 from $12

0 · Reply

OpenOutcrier Aug. 8 at 12:06 PM

$EMBC (+21.0% pre) Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results https://ooc.bz/l/73208

0 · Reply

stockstelegraph Aug. 8 at 11:29 AM

🚀 Pre-Market Movers on Fresh News 🚀 📈 $AIIO +16.15% – Big volume surge (73K+) pushing the EV play higher 📈 $TEM +11.90% – Strong demand with nearly 683K shares traded 📈 $EMBC +10.04% – Rallying despite a “Sell” analyst rating 📈 $MVST +8.89% – Analyst “Buy” rating fueling momentum 📈 $CYD +8.91% – Solid gains on light volume Eyes on these tickers — early movers often set the tone for the day. #Premarket #StocksToWatch #StockMarket

0 · Reply

JarvisFlow Jul. 16 at 12:31 PM

Mizuho has adjusted their stance on Embecta ( $EMBC ), setting the rating to Neutral with a target price of 13 → 12.

0 · Reply

Thestocktraderhubzee May. 23 at 5:45 PM

$EMBC Mizuho Maintains Neutral on Embecta, Lowers Price Target to $13

0 · Reply

JarvisFlow May. 23 at 5:41 PM

Mizuho updates rating for Embecta ( $EMBC ) to Neutral, target set at 15 → 13.

0 · Reply

iruril May. 23 at 5:59 AM

$EMBC rebuying with increased size

0 · Reply

AlarmedSheiky May. 22 at 6:39 PM

$EMBC What the hell did they say in that conference that wiped away 20% of their value??

0 · Reply

Market Cap	684.02M
Revenue (ttm)	1.08B
Net Income (ttm)	95.40M
EPS (ttm)	N/A
PE Ratio	3.93
Forward PE	4.03
Profit Margin	8.83%
Debt to Equity Ratio	-2.15

Volume	972,200
Avg Vol	455,686
Day's Range	N/A - N/A
Shares Out	58.51M
Stochastic %K	6%
Beta	1.10
Analysts	Sell
Price Target	$16.67